Li Long
Corporate Officer/Principal presso KEZAR LIFE SCIENCES, INC.
Profilo
Li Long is currently working as Vice President-Immunology Clinical Development at Kezar Life Sciences, Inc. Prior to this, Dr. Long worked as Senior Director-Clinical Development at Principia Biopharma, Inc. Dr. Long holds a doctorate degree from McGill University.
Posizioni attive di Li Long
| Società | Posizione | Inizio |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Li Long
| Società | Posizione | Fine |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | - |
Formazione di Li Long
| McGill University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Li Long
